 | • レポートコード：GIR-2104Z11097 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ポリオワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ポリオワクチンの種類別市場規模（IPV、OPV）、用途別市場規模（研究所、製薬・バイオテクノロジー企業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ポリオワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、GSK、Bibcol、Serum Institute、Tiantan Biological、IMBCA、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：IPV、OPV ・用途別分析2016年-2026年：研究所、製薬・バイオテクノロジー企業、その他 ・ポリオワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ポリオワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ポリオワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ポリオワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ポリオワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Poliomyelitis Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Poliomyelitis Vaccines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Poliomyelitis Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Poliomyelitis Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
IPV
OPV
Market segment by Application can be divided into
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
The key market players for global Poliomyelitis Vaccines market are listed below:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Poliomyelitis Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Poliomyelitis Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 IPV
1.2.3 OPV
1.3 Market Analysis by Application
1.3.1 Overview: Global Poliomyelitis Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Global Poliomyelitis Vaccines Market Size & Forecast
1.4.1 Global Poliomyelitis Vaccines Sales in Value (2016-2026))
1.4.2 Global Poliomyelitis Vaccines Sales in Volume (2016-2026)
1.4.3 Global Poliomyelitis Vaccines Price by Type (2016-2026) & (USD/Unit)
1.5 Global Poliomyelitis Vaccines Production Capacity Analysis
1.5.1 Global Poliomyelitis Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Poliomyelitis Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Poliomyelitis Vaccines Market Drivers
1.6.2 Poliomyelitis Vaccines Market Restraints
1.6.3 Poliomyelitis Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Poliomyelitis Vaccines Product and Services
2.1.4 Sanofi Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Poliomyelitis Vaccines Product and Services
2.2.4 GSK Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bibcol
2.3.1 Bibcol Details
2.3.2 Bibcol Major Business
2.3.3 Bibcol Poliomyelitis Vaccines Product and Services
2.3.4 Bibcol Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Serum Institute
2.4.1 Serum Institute Details
2.4.2 Serum Institute Major Business
2.4.3 Serum Institute Poliomyelitis Vaccines Product and Services
2.4.4 Serum Institute Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Tiantan Biological
2.5.1 Tiantan Biological Details
2.5.2 Tiantan Biological Major Business
2.5.3 Tiantan Biological Poliomyelitis Vaccines Product and Services
2.5.4 Tiantan Biological Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 IMBCA
2.6.1 IMBCA Details
2.6.2 IMBCA Major Business
2.6.3 IMBCA Poliomyelitis Vaccines Product and Services
2.6.4 IMBCA Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Panacea Biotec Ltd
2.7.1 Panacea Biotec Ltd Details
2.7.2 Panacea Biotec Ltd Major Business
2.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Product and Services
2.7.4 Panacea Biotec Ltd Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Bio-Med
2.8.1 Bio-Med Details
2.8.2 Bio-Med Major Business
2.8.3 Bio-Med Poliomyelitis Vaccines Product and Services
2.8.4 Bio-Med Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Halfkin Bio-Pharmaceuticals Details
2.9.2 Halfkin Bio-Pharmaceuticals Major Business
2.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product and Services
2.9.4 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Poliomyelitis Vaccines Sales by Manufacturer
3.1 Global Poliomyelitis Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Poliomyelitis Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Poliomyelitis Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Poliomyelitis Vaccines Manufacturer Market Share
3.4.2 Top 6 Poliomyelitis Vaccines Manufacturer Market Share
3.5 Global Poliomyelitis Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Poliomyelitis Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Poliomyelitis Vaccines Market Size by Region
4.1.1 Global Poliomyelitis Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Poliomyelitis Vaccines Revenue by Region (2016-2026)
4.2 North America Poliomyelitis Vaccines Revenue (2016-2026)
4.3 Europe Poliomyelitis Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Poliomyelitis Vaccines Revenue (2016-2026)
4.5 South America Poliomyelitis Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Poliomyelitis Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Poliomyelitis Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Poliomyelitis Vaccines Revenue by Type (2016-2026)
5.3 Global Poliomyelitis Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Poliomyelitis Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Poliomyelitis Vaccines Revenue by Application (2016-2026)
6.3 Global Poliomyelitis Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Poliomyelitis Vaccines Sales by Type (2016-2026)
7.2 North America Poliomyelitis Vaccines Sales by Application (2016-2026)
7.3 North America Poliomyelitis Vaccines Market Size by Country
7.3.1 North America Poliomyelitis Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Poliomyelitis Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Poliomyelitis Vaccines Sales by Type (2016-2026)
8.2 Europe Poliomyelitis Vaccines Sales by Application (2016-2026)
8.3 Europe Poliomyelitis Vaccines Market Size by Country
8.3.1 Europe Poliomyelitis Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Poliomyelitis Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Poliomyelitis Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Poliomyelitis Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Poliomyelitis Vaccines Market Size by Region
9.3.1 Asia-Pacific Poliomyelitis Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Poliomyelitis Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Poliomyelitis Vaccines Sales by Type (2016-2026)
10.2 South America Poliomyelitis Vaccines Sales by Application (2016-2026)
10.3 South America Poliomyelitis Vaccines Market Size by Country
10.3.1 South America Poliomyelitis Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Poliomyelitis Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Poliomyelitis Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Poliomyelitis Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Poliomyelitis Vaccines Market Size by Country
11.3.1 Middle East & Africa Poliomyelitis Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Poliomyelitis Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Poliomyelitis Vaccines Typical Distributors
12.3 Poliomyelitis Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Poliomyelitis Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Poliomyelitis Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Poliomyelitis Vaccines Product and Services
Table 6. Sanofi Poliomyelitis Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Poliomyelitis Vaccines Product and Services
Table 10. GSK Poliomyelitis Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bibcol Basic Information, Manufacturing Base and Competitors
Table 12. Bibcol Major Business
Table 13. Bibcol Poliomyelitis Vaccines Product and Services
Table 14. Bibcol Poliomyelitis Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 16. Serum Institute Major Business
Table 17. Serum Institute Poliomyelitis Vaccines Product and Services
Table 18. Serum Institute Poliomyelitis Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 20. Tiantan Biological Major Business
Table 21. Tiantan Biological Poliomyelitis Vaccines Product and Services
Table 22. Tiantan Biological Poliomyelitis Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. IMBCA Basic Information, Manufacturing Base and Competitors
Table 24. IMBCA Major Business
Table 25. IMBCA Poliomyelitis Vaccines Product and Services
Table 26. IMBCA Poliomyelitis Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Panacea Biotec Ltd Major Business
Table 29. Panacea Biotec Ltd Poliomyelitis Vaccines Product and Services
Table 30. Panacea Biotec Ltd Poliomyelitis Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 32. Bio-Med Major Business
Table 33. Bio-Med Poliomyelitis Vaccines Product and Services
Table 34. Bio-Med Poliomyelitis Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Halfkin Bio-Pharmaceuticals Major Business
Table 37. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product and Services
Table 38. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Poliomyelitis Vaccines Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Poliomyelitis Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Poliomyelitis Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Poliomyelitis Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Poliomyelitis Vaccines Production Site of Key Manufacturer
Table 44. Global Poliomyelitis Vaccines Sales by Region (2016-2021e) & (K Units)
Table 45. Global Poliomyelitis Vaccines Sales by Region (2021-2026) & (K Units)
Table 46. Global Poliomyelitis Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Poliomyelitis Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Poliomyelitis Vaccines Sales by Type (2016-2021e) & (K Units)
Table 49. Global Poliomyelitis Vaccines Sales by Type (2021-2026) & (K Units)
Table 50. Global Poliomyelitis Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Poliomyelitis Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Poliomyelitis Vaccines Price by Type (2016-2021e) & (USD/Unit)
Table 53. Global Poliomyelitis Vaccines Price by Type (2021-2026) & (USD/Unit)
Table 54. Global Poliomyelitis Vaccines Sales by Application (2016-2021e) & (K Units)
Table 55. Global Poliomyelitis Vaccines Sales by Application (2021-2026) & (K Units)
Table 56. Global Poliomyelitis Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Poliomyelitis Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Poliomyelitis Vaccines Price by Application (2016-2021e) & (USD/Unit)
Table 59. Global Poliomyelitis Vaccines Price by Application (2021-2026) & (USD/Unit)
Table 60. North America Poliomyelitis Vaccines Sales by Country (2016-2021e) & (K Units)
Table 61. North America Poliomyelitis Vaccines Sales by Country (2021-2026) & (K Units)
Table 62. North America Poliomyelitis Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Poliomyelitis Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Poliomyelitis Vaccines Sales by Type (2016-2021e) & (K Units)
Table 65. North America Poliomyelitis Vaccines Sales by Type (2021-2026) & (K Units)
Table 66. North America Poliomyelitis Vaccines Sales by Application (2016-2021e) & (K Units)
Table 67. North America Poliomyelitis Vaccines Sales by Application (2021-2026) & (K Units)
Table 68. Europe Poliomyelitis Vaccines Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Poliomyelitis Vaccines Sales by Country (2021-2026) & (K Units)
Table 70. Europe Poliomyelitis Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Poliomyelitis Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Poliomyelitis Vaccines Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Poliomyelitis Vaccines Sales by Type (2021-2026) & (K Units)
Table 74. Europe Poliomyelitis Vaccines Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Poliomyelitis Vaccines Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Poliomyelitis Vaccines Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Poliomyelitis Vaccines Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Poliomyelitis Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Poliomyelitis Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Poliomyelitis Vaccines Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Poliomyelitis Vaccines Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Poliomyelitis Vaccines Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Poliomyelitis Vaccines Sales by Application (2021-2026) & (K Units)
Table 84. South America Poliomyelitis Vaccines Sales by Country (2016-2021e) & (K Units)
Table 85. South America Poliomyelitis Vaccines Sales by Country (2021-2026) & (K Units)
Table 86. South America Poliomyelitis Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Poliomyelitis Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Poliomyelitis Vaccines Sales by Type (2016-2021e) & (K Units)
Table 89. South America Poliomyelitis Vaccines Sales by Type (2021-2026) & (K Units)
Table 90. South America Poliomyelitis Vaccines Sales by Application (2016-2021e) & (K Units)
Table 91. South America Poliomyelitis Vaccines Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Poliomyelitis Vaccines Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Poliomyelitis Vaccines Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Poliomyelitis Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Poliomyelitis Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Poliomyelitis Vaccines Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Poliomyelitis Vaccines Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Poliomyelitis Vaccines Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Poliomyelitis Vaccines Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Poliomyelitis Vaccines Typical Distributors
Table 103. Poliomyelitis Vaccines Typical Customers
List of Figures
Figure 1. Poliomyelitis Vaccines Picture
Figure 2. Global Poliomyelitis Vaccines Sales Market Share by Type in 2020
Figure 3. IPV
Figure 4. OPV
Figure 5. Global Poliomyelitis Vaccines Sales Market Share by Application in 2020
Figure 6. Research & Academic Laboratories
Figure 7. Pharmaceutical & Biotechnology Companies
Figure 8. Others
Figure 9. Global Poliomyelitis Vaccines Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Poliomyelitis Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Poliomyelitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Poliomyelitis Vaccines Sales (2016-2026) & (K Units)
Figure 31. Global Poliomyelitis Vaccines Production Capacity (2016-2026) & (K Units)
Figure 32. Global Poliomyelitis Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Poliomyelitis Vaccines Market Drivers
Figure 34. Poliomyelitis Vaccines Market Restraints
Figure 35. Poliomyelitis Vaccines Market Trends
Figure 36. Global Poliomyelitis Vaccines Sales Market Share by Manufacturer in 2020
Figure 37. Global Poliomyelitis Vaccines Revenue Market Share by Manufacturer in 2020
Figure 38. Poliomyelitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Poliomyelitis Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Poliomyelitis Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Poliomyelitis Vaccines Sales Market Share by Region (2016-2026)
Figure 42. Global Poliomyelitis Vaccines Revenue Market Share by Region (2016-2026)
Figure 43. North America Poliomyelitis Vaccines Revenue (2016-2026) & (USD Million)
Figure 44. Europe Poliomyelitis Vaccines Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Poliomyelitis Vaccines Revenue (2016-2026) & (USD Million)
Figure 46. South America Poliomyelitis Vaccines Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Poliomyelitis Vaccines Revenue (2016-2026) & (USD Million)
Figure 48. Global Poliomyelitis Vaccines Sales Market Share by Type (2016-2026)
Figure 49. Global Poliomyelitis Vaccines Revenue Market Share by Type (2016-2026)
Figure 50. Global Poliomyelitis Vaccines Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Poliomyelitis Vaccines Sales Market Share by Application (2016-2026)
Figure 52. Global Poliomyelitis Vaccines Revenue Market Share by Application (2016-2026)
Figure 53. Global Poliomyelitis Vaccines Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Poliomyelitis Vaccines Sales Market Share by Country (2016-2026)
Figure 55. North America Poliomyelitis Vaccines Revenue Market Share by Country (2016-2026)
Figure 56. North America Poliomyelitis Vaccines Sales Market Share by Type (2016-2026)
Figure 57. North America Poliomyelitis Vaccines Sales Market Share by Application (2016-2026)
Figure 58. Europe Poliomyelitis Vaccines Sales Market Share by Country (2016-2026)
Figure 59. Europe Poliomyelitis Vaccines Revenue Market Share by Country (2016-2026)
Figure 60. Europe Poliomyelitis Vaccines Sales Market Share by Type (2016-2026)
Figure 61. Europe Poliomyelitis Vaccines Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Poliomyelitis Vaccines Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Poliomyelitis Vaccines Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Poliomyelitis Vaccines Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Poliomyelitis Vaccines Sales Market Share by Application (2016-2026)
Figure 66. South America Poliomyelitis Vaccines Sales Market Share by Country (2016-2026)
Figure 67. South America Poliomyelitis Vaccines Revenue Market Share by Country (2016-2026)
Figure 68. South America Poliomyelitis Vaccines Sales Market Share by Type (2016-2026)
Figure 69. South America Poliomyelitis Vaccines Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Poliomyelitis Vaccines Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のポリオ（ポリオ）ワクチン市場 2021：企業別、地域別、種類・用途別 The Polio (Poliomyelitis) Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- 世界のヒトパピローマウイルス（HPV）ワクチン市場 2021：企業別、地域別、種類・用途別 The Human Papillomavirus (HPV) Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界のmRNAワクチン市場規模・現状・予測（2021年-2027年） When the mRNA encoding the antigenic protein is injected into the human body, the antigenic protein can be synthesized in the body, thus causing the human immune response against the pathogen infection, namely the mRNA vaccine. In 2021, the global mRNA Vaccines market size will be US$ XX million and…
- 世界のmRNAがんワクチン・治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global mRNA Cancer Vaccines and Therapeutics Market The global mRNA Cancer Vaccines and Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
- 世界のワクチン配達市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a…